Skip to main content
. 2018 Mar 6;27(6):1533–1544. doi: 10.1007/s11136-018-1825-4

Table 2.

Correlations between illness perception scales after diagnosis and HRQoL, anxiety and depression after 6, 12, and 24 months

Endometrial cancer Ovarian cancer
Illness perceptions after treatment Symptoms experienced Concerns Emotional impact Lower treatment trust
Months after treatment, outcome variables 6 18 24 6 18 24 6 18 24 6 18 24
N 158 147 128 158 147 128 158 147 128 124 101 75
Global quality of life − 0.24 − 0.25* − 0.21 − 0.25* − 0.29* − 0.34* − 0.29* − 0.29* − 0.29* − 0.42* − 0.40* − 0.36*
Function scales
 Physical functioning − 0.22 − 0.19 − 0.24 − 0.14 − 0.21 − 0.19 − 0.18 − 0.22 − 0.18 − 0.24 − 0.16 − 0.16
 Role functioning − 0.06 − 0.20 − 0.28* − 0.09 − 0.15 − 0.36* − 0.22 − 0.13 − 0.25 − 0.27 − 0.18 − 0.25
 Emotional functioning − 0.34* − 0.21 − 0.32* − 0.32* − 0.24 − 0.38* − 0.38* − 0.29* − 0.41* − 0.28* − 0.15 − 0.27
 Cognitive functioning − 0.17 − 0.07 − 0.25 − 0.14 − 0.17 − 0.28* − 0.17 − 0.06 − 0.22 − 0.19 − 0.29 − 0.34
 Social functioning − 0.41* − 0.28* − 0.32* − 0.23 − 0.29* − 0.38* − 0.33* − 0.27* − 0.27* − 0.16 − 0.07 − 0.26
Symptom scales
 Fatigue 0.36* 0.28* 0.34* 0.26 0.26 0.37 0.35* 0.31* 0.32* 0.26 0.14 0.29
 Nausea and vomiting 0.13 0.21 0.24 0.06 0.05 0.14 0.15 0.09 0.12 0.14 0.15 0.33
 Pain 0.23 0.17 0.26 0.20 0.23 0.39* 0.22 0.20 0.26 0.28* 0.19 0.33
 Dyspnea 0.18 0.19 0.11 0.07 0.14 0.14 0.15 0.15 0.20 0.20 0.02 0.23
 Insomnia 0.32* 0.17 0.25 0.23 0.19* 0.28* 0.30* 0.22 0.26 0.31* 0.20 0.18
 Appetite loss 0.28* 0.16 0.23 0.18 0.03 0.28* 0.27* 0.14 0.24 0.22 0.09 0.44*
 Constipation 0.04 0.03 0.09 0.11 0.02 0.22 0.14 0.08 0.22 0.21 0.21 0.14
 Diarrhea 0.18 0.11 0.13 0.15 0.11 0.05 0.21 0.08 0.14 0.06 < 0.01 0.13
 Financial difficulties 0.30* 0.20* 0.20 0.17 0.08 0.11 0.21 0.10 0.08 0.16 0.09 − 0.08
Anxiety 0.30* 0.33* 0.34* 0.41* 0.45* 0.46* 0.46* 0.47* 0.45* 0.39* 0.31 0.24
Depression 0.39* 0.28* 0.23* 0.35* 0.35* 0.36* 0.39* 0.33* 0.34* 0.40* 0.25 0.38*

Pearson’s correlations were estimated between illness perceptions measured after diagnosis, and outcome variables after diagnosis and 6, 12, and 24 months after diagnosis. Only the illness perception items were included that have earlier been associated with trial allocation

*p < 0.003 (adjusted for Bonferroni correction 0.05/1)